Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Three-armed, Randomized, Double-blind Dose-finding Trial on Efficiency and Safety of AK 3012 in 3 Different Concentrations in Patients With Actinic Keratosis Olsen Grade I/II

NCT01757613 is registered in ClinicalTrials.gov with Dolorgiet GmbH & Co. KG as lead sponsor.

NCT NCT01757613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01757613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Three-armed, Randomized, Double-blind Dose-finding Trial on Efficiency and Safety of AK 3012 in 3 Different Concentrations in Patients With Actinic Keratosis Olsen Grade I/II
Lead sponsor
Dolorgiet GmbH & Co. KG
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2012
Completion date
January 31, 2014
Enrollment
150 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis olsen grade i/ii